World Cord Blood Day takes place on November 15, 2019, and will provide an opportunity for parents, doctors, nurses and midwives to learn about the current and future uses of cord blood stem cells, and the potential cord blood has to save lives.
Cord blood is now being used to treat and cure over 80 different life-threatening diseases, including leukaemia, lymphoma and sickle cell anaemia. It is also proving critical to new areas of regenerative medicine to potentially treat spinal cord injuries, cerebral palsy, autism, type 1 diabetes and much more. Stem cells for transplants come from the blood of the umbilical cord collected after a baby is born.
Quick, the leading transportation provider of cord blood, stem cells and umbilical cords is sponsoring WCBD for the third year and will host a session on how to safely transport cord blood and derivative therapies. Industry veterans David Murphy and Monroe Burgess of Quick will discuss the critical steps for safe and secure transit of umbilical cord cells. Since babies arrive in the world on their own time frame, the logistics of cord blood collection and transportation must be carefully planned to ensure integrity and viability.
"All of us at Quick are proud to sponsor World Cord Blood Day to help educate the healthcare community and expectant parents about the life-saving value of cord blood cells. We're excited to play a role in the research and development of cord blood derivative therapies by providing logistics supply chain solutions to cord blood, biotech and pharmaceutical companies worldwide," said David Murphy, Executive VP of Quick's Life Science Division.
For more information about World Cord Blood Day, organized by Save the Cord Foundation, visit here.